Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Survival Analysis [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
CRC [NCBI] 0.00530299
KLK3 [NCBI] 0.0019441
EGFR [NCBI] 0.00125068
lymphoma, non-hodgkin, familial [NCBI] 0.00113234
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 0.00109936
CEACAM5 [NCBI] 0.00100228
VEGF [NCBI] 0.000856602
CHDM [NCBI] 0.00082871
PARK3 [NCBI] 0.000638637
WM1 [NCBI] 0.000638637
IBD5 [NCBI] 0.000619728
telomere length, mean leukocyte [NCBI] 0.000602566
leber optic atrophy, susceptibility to [NCBI] 0.000572382
IGAN1 [NCBI] 0.000523734
PCNA [NCBI] 0.000459666
TYMS [NCBI] 0.000418849
behcet syndrome [NCBI] 0.000392978
klippel-trenaunay-weber syndrome [NCBI] 0.000369043
human immunodeficiency virus type 1, susceptibility to [NCBI] 0.000330777
GIST [NCBI] 0.000307823
AFP [NCBI] 0.000302501
EGF [NCBI] 0.000215723
LAM [NCBI] 0.000186562
RA [NCBI] 0.000162633
JMML [NCBI] 0.000153104
NPY [NCBI] 0.0001421
PRL [NCBI] 0.000139023
PGR [NCBI] 0.000138278
NGFB [NCBI] 0.000127217
glioma of brain, familial [NCBI] 0.000110734
pulmonary hemosiderosis [NCBI] 9.4641e-05
furlong syndrome: fs [NCBI] 9.4641e-05
CMH2 [NCBI] 9.4641e-05
ALK [NCBI] 8.72458e-05
myeloma, multiple [NCBI] 8.64265e-05
ACHE [NCBI] 8.6304e-05
CRH [NCBI] 8.31191e-05
AVP [NCBI] 8.2589e-05
PTH [NCBI] 7.70309e-05
CCND1 [NCBI] 7.5134e-05
TH [NCBI] 7.29693e-05
ASPS [NCBI] 7.10342e-05
papillary thyroid microcarcinoma [NCBI] 6.70457e-05
MGMT [NCBI] 6.4183e-05
BL [NCBI] 6.28318e-05
stroke, ischemic [NCBI] 6.22644e-05
GFAP [NCBI] 6.21848e-05
MBP [NCBI] 5.93234e-05
PSNP1 [NCBI] 5.69205e-05
ANG [NCBI] 5.57971e-05
CHAT [NCBI] 5.45985e-05
PLAUR [NCBI] 5.22211e-05
BDNF [NCBI] 5.18727e-05
FGFR4 [NCBI] 5.17357e-05
SLE [NCBI] 5.05113e-05
ARVD9 [NCBI] 5.0112e-05
SKP2 [NCBI] 4.59374e-05
temporal arteritis [NCBI] 4.57663e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii [NCBI] 4.52284e-05
ovarian cancer, epithelial [NCBI] 4.52284e-05
NPHP4 [NCBI] 4.52284e-05
MDD [NCBI] 4.30265e-05
ABCC1 [NCBI] 4.24181e-05
CLL [NCBI] 4.161e-05
ZNF217 [NCBI] 3.86993e-05
CAT [NCBI] 3.81185e-05
CFTR [NCBI] 3.79122e-05
danubian endemic familial nephropathy [NCBI] 3.75356e-05
thrombocytopenic purpura, autoimmune [NCBI] 3.40406e-05
hydrops-ectopic calcification-moth-eaten skeletal dysplasia [NCBI] 3.31712e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative [NCBI] 3.31712e-05
IS [NCBI] 3.31712e-05
NPHP3 [NCBI] 3.31712e-05
immunoosseous dysplasia, schimke type [NCBI] 3.31712e-05
CMH4 [NCBI] 3.31712e-05
SCIDX1 [NCBI] 3.30606e-05
aortic valve disease [NCBI] 3.30606e-05
PWS [NCBI] 3.27909e-05
NPPA [NCBI] 3.25157e-05
LPL [NCBI] 3.22926e-05
CJD [NCBI] 3.21211e-05
PTGS2 [NCBI] 3.19916e-05
erythermalgia, primary [NCBI] 3.11191e-05
GPD2 [NCBI] 3.053e-05
TNF [NCBI] 2.94135e-05
RMS2 [NCBI] 2.92909e-05
TS [NCBI] 2.85281e-05
MTM1 [NCBI] 2.77932e-05
CCND2 [NCBI] 2.68562e-05
LDS [NCBI] 2.61527e-05
ADA [NCBI] 2.55199e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 2.47887e-05
ACPP [NCBI] 2.46918e-05
SPP1 [NCBI] 2.37168e-05
esophageal cancer [NCBI] 2.35351e-05
PHA [NCBI] 2.13027e-05
longevity [NCBI] 2.13027e-05
CSF3 [NCBI] 2.11696e-05
NRG4 [NCBI] 2.10887e-05
GCET2 [NCBI] 2.10887e-05
PLK1 [NCBI] 2.06964e-05
AVSD [NCBI] 2.03134e-05
MYH7 [NCBI] 2.03077e-05
CCNE1 [NCBI] 2.01217e-05
APC [NCBI] 1.96628e-05
FLT3 [NCBI] 1.95841e-05
IBD1 [NCBI] 1.94916e-05
brugada syndrome 1 [NCBI] 1.93671e-05
VWM [NCBI] 1.93671e-05
AMPD1 [NCBI] 1.90736e-05
HLA-DQB1 [NCBI] 1.90736e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 1.84908e-05
ORW2 [NCBI] 1.84908e-05
polycythemia vera [NCBI] 1.84908e-05
MEN2B [NCBI] 1.84908e-05
PHF20 [NCBI] 1.80191e-05
MDGA1 [NCBI] 1.80191e-05
RPL30 [NCBI] 1.80191e-05
IRAK1 [NCBI] 1.80191e-05
EPHB6 [NCBI] 1.80191e-05
JAK3 [NCBI] 1.77839e-05
HLA-DRB1 [NCBI] 1.76818e-05
hyperoxaluria, primary, type i [NCBI] 1.76673e-05
protein c deficiency, congenital thrombotic disease due to [NCBI] 1.71146e-05
TFF3 [NCBI] 1.68993e-05
aortic aneurysm, abdominal [NCBI] 1.68915e-05
ulcerative colitis, susceptibility to [NCBI] 1.68915e-05
G6PD [NCBI] 1.66981e-05
IL10 [NCBI] 1.64796e-05
TNNT2 [NCBI] 1.64628e-05
GPX1 [NCBI] 1.64628e-05
MFS [NCBI] 1.60932e-05
VCP [NCBI] 1.60739e-05
HGF [NCBI] 1.58031e-05
myopathy, myofibrillar, desmin-related [NCBI] 1.54665e-05
LIP [NCBI] 1.54665e-05
TGFBR2 [NCBI] 1.53814e-05
DCK [NCBI] 1.51099e-05
GDNF [NCBI] 1.51083e-05
NEM3 [NCBI] 1.48101e-05
PBD [NCBI] 1.48101e-05
ehlers-danlos syndrome, type iv, autosomal dominant [NCBI] 1.48101e-05
PPARA [NCBI] 1.47966e-05
RPS20 [NCBI] 1.45811e-05
CXCR6 [NCBI] 1.45811e-05
COL13A1 [NCBI] 1.45811e-05
TRO [NCBI] 1.45811e-05
SSX4 [NCBI] 1.45811e-05
GPD1 [NCBI] 1.45811e-05
lung cancer [NCBI] 1.41871e-05
hepatocellular carcinoma [NCBI] 1.41871e-05
COMT [NCBI] 1.41332e-05
DAP [NCBI] 1.38186e-05
PIGA [NCBI] 1.38186e-05
VDR [NCBI] 1.37249e-05
BCL6 [NCBI] 1.35359e-05
FMF [NCBI] 1.34469e-05
KIR2DL3 [NCBI] 1.34266e-05
ARMET [NCBI] 1.34266e-05
DEAF1 [NCBI] 1.34266e-05
OPCML [NCBI] 1.34266e-05
MLLT2 [NCBI] 1.34266e-05
KIR2DL2 [NCBI] 1.34266e-05
HOXB2 [NCBI] 1.34266e-05
FDXR [NCBI] 1.34266e-05
NPHP3 [NCBI] 1.34266e-05
FOXP1 [NCBI] 1.34266e-05
ADRA2C [NCBI] 1.34266e-05
AHR [NCBI] 1.33493e-05
APOB [NCBI] 1.31668e-05
HDGF [NCBI] 1.29962e-05
fabry disease [NCBI] 1.28621e-05
alzheimer disease 3 [NCBI] 1.24944e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i [NCBI] 1.24944e-05
SMN2 [NCBI] 1.24878e-05
CCL7 [NCBI] 1.24738e-05
MIRN15A [NCBI] 1.24738e-05
HBB [NCBI] 1.20236e-05
RP3 [NCBI] 1.19821e-05
CTF1 [NCBI] 1.16644e-05
INHBB [NCBI] 1.16644e-05
PI5 [NCBI] 1.16644e-05
KLK5 [NCBI] 1.16644e-05
TLX3 [NCBI] 1.16644e-05
DEFA3 [NCBI] 1.16644e-05
ELK3 [NCBI] 1.16644e-05
AR [NCBI] 1.14611e-05
KRT20 [NCBI] 1.12654e-05
gastric cancer [NCBI] 1.10251e-05
PRDX1 [NCBI] 1.09621e-05
NFE2L2 [NCBI] 1.09621e-05
SS18 [NCBI] 1.09621e-05
MIRN16-1 [NCBI] 1.09621e-05
CTAG1B [NCBI] 1.09621e-05
PKP2 [NCBI] 1.09621e-05
RPL19 [NCBI] 1.09621e-05
PARK2 [NCBI] 1.05775e-05
WAS [NCBI] 1.05044e-05
RARRES1 [NCBI] 1.03431e-05
CCL11 [NCBI] 1.03431e-05
TNFSF15 [NCBI] 1.03431e-05
GRB7 [NCBI] 1.03431e-05
ERBB3 [NCBI] 1.03431e-05
MTAP [NCBI] 1.03243e-05
CML [NCBI] 1.0149e-05
leber optic atrophy [NCBI] 1.00379e-05
PDCD1LG1 [NCBI] 9.79062e-06
CTSE [NCBI] 9.79062e-06
B2M [NCBI] 9.77434e-06
CADASIL [NCBI] 9.73831e-06
ALB [NCBI] 9.52317e-06
CMH [NCBI] 9.50763e-06
SMA3 [NCBI] 9.34448e-06
UBQLN1 [NCBI] 9.29244e-06
CX3CR1 [NCBI] 9.29244e-06
BAI1 [NCBI] 9.29244e-06
BCAR1 [NCBI] 9.29244e-06
ZNF148 [NCBI] 9.29244e-06
KIR2DL1 [NCBI] 9.29244e-06
NFKB1 [NCBI] 9.26113e-06
DCC [NCBI] 9.09756e-06
TG [NCBI] 9.02702e-06
CVID [NCBI] 8.96766e-06
ZAP70 [NCBI] 8.83949e-06
KRT18 [NCBI] 8.83949e-06
RECK [NCBI] 8.83949e-06
CSE1L [NCBI] 8.83949e-06
ERBB4 [NCBI] 8.83949e-06
USP7 [NCBI] 8.83949e-06
CYP1A1 [NCBI] 8.76192e-06
METAP2 [NCBI] 8.42481e-06
ATP1A1 [NCBI] 8.42481e-06
MCOLN1 [NCBI] 8.42481e-06
KCNJ1 [NCBI] 8.42481e-06
EIF2B5 [NCBI] 8.42481e-06
MBD2 [NCBI] 8.42481e-06
EPO [NCBI] 8.38209e-06
ANTXR1 [NCBI] 8.0429e-06
SSX1 [NCBI] 8.0429e-06
CCL3 [NCBI] 8.0429e-06
LMO2 [NCBI] 8.0429e-06
CD14 [NCBI] 8.0429e-06
SHBG [NCBI] 7.88384e-06
RTT [NCBI] 7.78887e-06
TNC [NCBI] 7.75728e-06
NTRK3 [NCBI] 7.68939e-06
MYBPC3 [NCBI] 7.68939e-06
PLAU [NCBI] 7.68939e-06
MMP13 [NCBI] 7.68939e-06
XDH [NCBI] 7.67972e-06
panencephalitis, subacute sclerosing [NCBI] 7.58291e-06
PGF [NCBI] 7.36073e-06
THBD [NCBI] 7.36073e-06
PLA2G2A [NCBI] 7.36073e-06
ADRB1 [NCBI] 7.36073e-06
TXN [NCBI] 7.36073e-06
HSAN3 [NCBI] 7.28771e-06
CCR5 [NCBI] 7.25517e-06
HP [NCBI] 7.15563e-06
NSD1 [NCBI] 7.05398e-06
CCR2 [NCBI] 7.05398e-06
SMAD3 [NCBI] 7.05398e-06
SLC7A5 [NCBI] 7.05398e-06
VCAM1 [NCBI] 6.7667e-06
TGFBR1 [NCBI] 6.7667e-06
DEFA1 [NCBI] 6.7667e-06
MMP12 [NCBI] 6.49684e-06
TKT [NCBI] 6.49684e-06
CRHR1 [NCBI] 6.49684e-06
ALGS1 [NCBI] 6.42537e-06
NNMT [NCBI] 6.24266e-06
MME [NCBI] 6.24266e-06
SCA6 [NCBI] 6.15881e-06
F3 [NCBI] 6.08718e-06
SSTR2 [NCBI] 6.00267e-06
ABCC3 [NCBI] 6.00267e-06
ANXA1 [NCBI] 6.00267e-06
neuroblastoma [NCBI] 5.90193e-06
MYB [NCBI] 5.77556e-06
CYCS [NCBI] 5.77556e-06
DBH [NCBI] 5.77556e-06
CTSB [NCBI] 5.56023e-06
HHT [NCBI] 5.4156e-06
sickle cell anemia [NCBI] 5.4156e-06
NF2 [NCBI] 5.4156e-06
MODY [NCBI] 5.41313e-06
NUP98 [NCBI] 5.35568e-06
BIRC5 [NCBI] 5.35568e-06
CRP [NCBI] 5.16106e-06
ALCAM [NCBI] 5.16106e-06
MYH9 [NCBI] 5.16106e-06
MTM1 [NCBI] 4.97559e-06
NRAS [NCBI] 4.97559e-06
ABCG2 [NCBI] 4.90585e-06
CDC42 [NCBI] 4.79861e-06
CRYAB [NCBI] 4.79861e-06
MYD88 [NCBI] 4.79861e-06
TF [NCBI] 4.76046e-06
FABP2 [NCBI] 4.46773e-06
THRA [NCBI] 4.46773e-06
hurler syndrome [NCBI] 4.34331e-06
CHUK [NCBI] 4.3128e-06
TNFSF6 [NCBI] 4.2494e-06
TTR [NCBI] 4.16858e-06
GCDH [NCBI] 4.16426e-06
MSH6 [NCBI] 4.16426e-06
NCOA3 [NCBI] 4.16426e-06
CD40LG [NCBI] 4.16426e-06
OSM [NCBI] 4.14637e-06
IL1A [NCBI] 4.02173e-06
ERCC2 [NCBI] 4.02173e-06
CXCL12 [NCBI] 3.88484e-06
HLA-B [NCBI] 3.88484e-06
LQT1 [NCBI] 3.78635e-06
GRPR [NCBI] 3.75325e-06
PTK2 [NCBI] 3.75017e-06
IL2 [NCBI] 3.68253e-06
IFNA1 [NCBI] 3.54843e-06
GNRH1 [NCBI] 3.52477e-06
RDT [NCBI] 3.44685e-06
INHBA [NCBI] 3.3874e-06
ALD [NCBI] 3.33347e-06
PSCA [NCBI] 3.27424e-06
FN1 [NCBI] 3.27424e-06
CHEK2 [NCBI] 3.16509e-06
STAR [NCBI] 3.09297e-06
EDNRB [NCBI] 3.05976e-06
CP [NCBI] 2.9922e-06
porphyria variegata [NCBI] 2.98107e-06
gaucher disease, type i [NCBI] 2.98107e-06
GRN [NCBI] 2.95806e-06
EGR1 [NCBI] 2.85981e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 2.83664e-06
TFR2 [NCBI] 2.76486e-06
ADIPOQ [NCBI] 2.67305e-06
LPA [NCBI] 2.67305e-06
DMD [NCBI] 2.36405e-06
APCS [NCBI] 2.33462e-06
IFNG [NCBI] 2.33462e-06
ERBB2 [NCBI] 2.33462e-06
glycogen storage disease ii [NCBI] 2.30872e-06
TLR5 [NCBI] 2.25662e-06
ALS1 [NCBI] 2.18842e-06
COL3A1 [NCBI] 2.18104e-06
MG [NCBI] 2.1797e-06
MAP2 [NCBI] 2.12928e-06
RHO [NCBI] 2.08911e-06
HD [NCBI] 2.00832e-06
FA [NCBI] 1.90049e-06
DFSP [NCBI] 1.90024e-06
PDCD8 [NCBI] 1.81781e-06
MSH2 [NCBI] 1.77363e-06
TFRC [NCBI] 1.77363e-06
RPGR [NCBI] 1.59609e-06
PTEN [NCBI] 1.57806e-06
PJS [NCBI] 1.52364e-06
MMP9 [NCBI] 1.48624e-06
AQP4 [NCBI] 1.4337e-06
MTND4 [NCBI] 1.4337e-06
fragile x mental retardation syndrome [NCBI] 1.41534e-06
NF2 [NCBI] 1.38269e-06
LCN2 [NCBI] 1.33315e-06
CNTF [NCBI] 1.32197e-06
MPO [NCBI] 1.30013e-06
BCL2 [NCBI] 1.23832e-06
EIF4E [NCBI] 1.23832e-06
BIRC1 [NCBI] 1.23832e-06
SOD1 [NCBI] 1.23417e-06
FTD [NCBI] 1.21786e-06
NOTCH1 [NCBI] 1.19294e-06
PSEN1 [NCBI] 1.19005e-06
TP53 [NCBI] 1.15147e-06
GPT [NCBI] 1.14887e-06
RB1 [NCBI] 1.14868e-06
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 1.13008e-06
CGD [NCBI] 1.13008e-06
LS [NCBI] 1.13008e-06
BRCA1 [NCBI] 1.07464e-06
CCL2 [NCBI] 1.0645e-06
REG3A [NCBI] 1.0645e-06
FRAP1 [NCBI] 1.04088e-06
MAPK3 [NCBI] 1.02413e-06
PLG [NCBI] 1.02023e-06
PD [NCBI] 9.56277e-07
TLR2 [NCBI] 9.49215e-07
CHS [NCBI] 9.22909e-07
THRB [NCBI] 9.09866e-07
MVP [NCBI] 8.73964e-07
JAK2 [NCBI] 8.46109e-07
BWS [NCBI] 8.40215e-07
CF [NCBI] 8.18906e-07
PARK2 [NCBI] 8.05264e-07
MLH1 [NCBI] 8.05264e-07
CDK4 [NCBI] 7.87687e-07
PTHLH [NCBI] 7.78648e-07
TNFRSF11B [NCBI] 7.30571e-07
factor v deficiency [NCBI] 6.22177e-07
BSG [NCBI] 6.22177e-07
SST [NCBI] 5.48303e-07
GAPDH [NCBI] 5.47283e-07
STAT3 [NCBI] 5.41251e-07
ZFP36 [NCBI] 5.17498e-07
VHL [NCBI] 5.17498e-07
MUC1 [NCBI] 4.95213e-07
SMAX1 [NCBI] 4.85777e-07
PEDF [NCBI] 4.65595e-07
LBP [NCBI] 4.04028e-07
SMN1 [NCBI] 3.83483e-07
MBL2 [NCBI] 3.63617e-07
WHS [NCBI] 3.45227e-07
MEN1 [NCBI] 3.44422e-07
TFPI [NCBI] 2.91505e-07
krabbe disease [NCBI] 2.7428e-07
APOE [NCBI] 2.70339e-07
INS [NCBI] 2.58268e-07
APP [NCBI] 2.38716e-07
ILK [NCBI] 2.35617e-07
KCNH2 [NCBI] 2.35617e-07
IL4 [NCBI] 2.27586e-07
DBA [NCBI] 2.12318e-07
FGF7 [NCBI] 1.8757e-07
hemophilia a [NCBI] 1.8032e-07
GUSB [NCBI] 1.61379e-07
VHL [NCBI] 1.35426e-07
SRC [NCBI] 1.27917e-07
SCZD [NCBI] 1.13903e-07
GPI [NCBI] 8.51189e-08
polycystic kidneys [NCBI] 6.66816e-08
SDC2 [NCBI] 6.65038e-08
CTGF [NCBI] 6.64026e-08
BCR [NCBI] 6.16641e-08
ABCC8 [NCBI] 5.95268e-08
PPARG [NCBI] 5.29645e-08
TLR9 [NCBI] 4.68191e-08
SOD2 [NCBI] 4.44415e-08
NGFR [NCBI] 4.01613e-08
NPM1 [NCBI] 3.57513e-08
PPIA [NCBI] 3.57513e-08
MECP2 [NCBI] 3.56071e-08
ABCB1 [NCBI] 3.56071e-08
PKD1 [NCBI] 3.08157e-08
hla-d histocompatibility type [NCBI] 2.83089e-08
AD [NCBI] 2.68299e-08
PON1 [NCBI] 1.99847e-08
SPINK1 [NCBI] 1.83256e-08
MAPT [NCBI] 1.83256e-08
PTN [NCBI] 1.83256e-08
IGFALS [NCBI] 6.85444e-09
MS [NCBI] 1.85353e-09
NF1 [NCBI] 1.24187e-09
RET [NCBI] 9.7834e-10
SLPI [NCBI] 3.44488e-10
BRCA2 [NCBI] 3.48665e-11
CDK2 [NCBI] 3.19899e-13



Database Center for Life Science